With the aging of the population and changes in lifestyle in China, the number of patients with diabetic infra-popliteal artery occlusion has been growing. Revascularization is of great significance for improving the limb salvage rate and survival rate of patients. By comparing open surgery and endovascular revascularization techniques, although open surgery can improve lower limb ischemia, it has significant trauma and numerous complications. Endovascular treatment, which includes procedures such as lumen recanalization, lumen preparation, and lumen maintenance, has become the preferred option due to its advantages such as minimal trauma. The lumen recanalization technique has continuously advanced with the helping of new devices and the accumulation of experience. Lumen preparation encompasses various methods such as balloon dilation and debulking techniques to address different lesions. In lumen maintenance, drug-coated balloon (DCB) have a certain effect in inhibiting smooth muscle proliferation and improving long-term patency rates. However, the safety of paclitaxel on DCB remains controversial. Stent implantation is not currently recommended due to the characteristics of the infra-popliteal arteries such as small lumen, long lesions, and severe calcification. At present, revascularization for diabetic infra-popliteal artery occlusion still faces challenges. Research on angiogenesis therapy is expected to bring new breakthroughs, and the future development of this field requires the integration of multiple disciplines. This article reviews the development history of revascularization for diabetic infra-popliteal artery lesions, and expounds the transformation of its treatment concept from early arbitrary recanalization to the precise Angiographsome concept.

Objective:To explore expression of VSIG4 in clear cell renal cell carcinoma(ccRCC)and its correlation with immune cells infiltration and prognosis.Methods:RNA-seq data of ccRCC and corresponding clinical data of patients were downloaded from The Cancer Genome Atlas(TCGA)database.Wilcoxon rank-sum test was used to analyze VSIG4 mRNA expression in ccRCC and normal renal tissues.Correlation between VSIG4 expression and clinicopathological parameters was analyzed by Wilcoxon rank-sum or Kruskal-Wallis rank-sum test.Kaplan-Meier method was used to analyze the correlation between VSIG4 expression and progno-sis of patients.Gene set enrichment analysis(GSEA)was used to explore the signaling pathway of VSIG4 in ccRCC.Correlation between VSIG4 level and tumor infiltrating immune cells was analyzed via CIBERSORT in R software.Western blotting was used to detect VSIG4 protein level in human renal epithelial cell line 293T,and human renal carcinoma cell line ACHN,A498,786-O and OS-RC-2.Results:Expression level of VSIG4 in ccRCC was significantly higher than that in normal tissues(P<0.05).VSIG4 expression was significantly correlated with the stages of distant metastasis and lymph node metastasis(P<0.05).Overall survival rate of patients with high VSIG4 expression was significantly lower than that of patients with low expression(P<0.05).GSEA enrichment analysis showed that VSIG4 was mainly enriched in apoptosis,chemokine signaling pathway,cell adhesion molecules and other signaling path-ways.VSIG4 expression was negatively correlated with M1 macrophages(r<0,P<0.05),while positively correlated with M2 macro-phages(r>0,P<0.05).Western blotting results showed that expression of VSIG4 in renal cell carcinoma cells was higher than that in normal renal cells.Conclusion:VSIG4 is highly expressed in ccRCC,and is negatively associated with prognosis,which may become a prognostic biomarker for ccRCC patients.